dba

 

Therapeutic Antibodies

Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. Based on rich experience and advanced research and development platform, Creative Biolabs has established a "one-stop" antibody technology service system to meet the needs of antibody drug research and development, and to provide customers with economical professional antibody research and development services and high-quality antibody products.

Advantages of Therapeutic Antibodies:

Endotoxin free

High affinity

High purity

Long-term benefit with short-term therapy

Hot Recombinant Antibodies Listed as Follows:

Cat No.

Product Name

TAB-161

Gevokizumab

PABL-049

Recombinant Human Anti-CMV gH Antibody (MSL-109)

TAB-754

Anti-CFD Therapeutic Antibody

TP-092CL

Eculizumab

TAB-175

Bavituximab

TAB-H75

vedolizumab

TAB-022

Natalizumab

PABW-133

Recombinant Mouse Anti-Y-DOTA Antibody (2D12.5)

PABL-322

Recombinant Human Anti-RSV Antibody (D25)

PABZ-148

Recombinant Anti-P. vivax AMA1 Antibody (F8.12.19)

TAB-418MZ

Product ID Anti-Human MUC1 Therapeutic Antibody (5E5)

TAB-201

Amatuximab

TAB-104

Siplizumab

TAB-0792CLV

Anti-Human APP Therapeutic Antibody (NAB61)

MRO-1131LC

Anti-DENV1 E Therapeutic Antibody (HM14c10)

TAB-067

Anti-Human CTLA4 Therapeutic Antibody (Yervoy)



 

Richiedi un'offerta

DBA-ITALIA Srl
Via Umbria 10
20090 Segrate (Milano)

Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535




If you no longer wish to receive these announcements click here